Panacea Life Sciences Holdings Inc · OTC:PLSH

Panacea Life Sciences — Exactus — Investor Presentation (June 2019)

18 slides from Panacea Life Sciences's investor presentation, Jun 3, 2019

  1. Slide 1: Hemp-Derived CBD: From the Best Genetics to the Best Products

    EXAC=:US ~ HEMP-DERIVED CBD FROM THE BEST GENETICS TO THE BEST PRODUCTS ivrene Bra

  2. Slide 2: Statements

    STATEMENTS “This presentation i for informational purposes and nothing contained hersin isan ote o sel ora solctaton of an offer to buy any secures, ‘and may net be roid upon in connect with the purchase or sale of any secur. Any offering or solictation wil be made ony fo qualified ‘rospectve invest

  3. Slide 3: Our Mission

    Our Mission ‘CORE VALUES + Ourmissionis to become the most usted name inthe hemp-derved CBD marke, setting the standard of qualty and wansparency. + We are focused on developing and producing hemp derived products for human and animal consumption. + Our products ar grown from certtied gonetic, organ

  4. Slide 4: Corporate Overview

    CORPORATE OVERVIEW Operating Goals + Private Labet and Exact Branded Hemp- Derived CBO Products + Majority Intros ia 200 Ace Indusval Hemp Farm + Assisting Medical and Heath-Care Professionals wit Hemp Derived Education and Prosucts + Pharmacy Sales of Homp Derived 44 OTC-OB SYMBOLEXOr + Fully eperi

  5. Slide 5: USA Hemp/CBD Market Opportunity

    USA HEMP/CBD MARKET OPPORTUNITY $367M “4 ea, 2017 - Sales of $367M and 2018. Hemp derived CBD ‘The US market for Hemp ‘expected to bo >S500M in ‘market gronth outpacing all reprosenis a massive opportunity 2018" ‘other cannabinoids 10 early movers and innovators la ~60% “The Brightlé Group estimates

  6. Slide 6: The Exactus Advantage

    THE EXACTUS ADVANTAGE ‘Master Development and Supply Exactus Products 200 Acros of Femiand in Southwest ‘Agreement 1 Falspearonvncte pnt enact andiaite Oregon Parmer we Conca, ot rest senmerpeace eng mets 10 8 ‘Durer fr deacatedsppysbamass, + lcreodng revene opportunity wth ‘passa ars | (rn. scl att

  7. Slide 7: Exclusive Manufacturing and Development Partnership

    EXCLUSIVE MANUFACTURING AND DEVELOPMENT PARTNERSHIP Er ‘Mult year Master Supply and Development SD vorneoe @, Access to existing and future customer > eeiatonsnios ‘Superior biomass for production of isolates in dodeated faciios 1” Sat apoyo coc for 2.500 los analy ‘Owned and inased domeste and item

  8. Slide 8: Exactus Branded Products

    Exactus Branded Products + Full spectrum whole plant extract and isolate + Trusted quality assurance through third party lab testing & GNP for all of our CBD products + Full raceabiity rom seed all the way tothe finished product £ ey na se = = om EXACSUS EXACEUS

  9. Slide 9: Seed to Sale Tracking

    SEED TO SALE TRACKING EXACEUS

  10. Slide 10: Planning & Preparation / Production & Manufacturing

    Panning & Preparation Farming techniques ‘rae eng teraiogy ‘Scane pine o masini CBD cencanaon an Production & Manulacturing ‘began n Apt 2019 hus taunching the start of [Envacuonandmanuacting are done Wax) ‘Tne Company is investigating abroad number of proprietary CBO derived products and technology

  11. Slide 11: Scalar Exactus One World Fairness Opinion

    Scalar Exactus One World Fairness Opinion ‘The Assumptions Scalar's Analysis - Enterprise Value Range’ + The applied revenue multiple ‘was tested inthe revenue ‘multiple terminal value + Thelong erm growth rate was testo in the perpotty sted Teil tue ‘ronth terminal valve Spproach, with an average l

  12. Slide 12: Investment Highlights

    INVESTMENT HIGHLIGHTS Leading the development of industry qualty standarés $1 millon inital purchase * rac banded posits “ireures 1 topes 1 eee ‘Sot Gel Capses ce] [Master Product Development and Supply Agreement Provides existing relatonships with farmers, manufacturers, ‘nd distibutors for multipl

  13. Slide 13: Management

    MANAGEMENT PHILIP J YOUNG. CHAIRMAN AND CEO EMILIANO ALO! PRESIDENT & SENIOR ANDREW L. JOHNSON CHIEF STRATEGY ‘OFFICER EXACEUS

  14. Slide 14: Advisory Board

    ADVISORY BOARD TROY RHONEMUS SENIOR ADVISOR from20t0%0 2013 1 areas aba ecg sas ce con by 20% + Tv egy Manger Coe on tran fom ik aca acess ott um nto tose & EMILIANO ALO! PRESIDENT & SENIOR ADVISOR EXACEUS

  15. Slide 15: Board of Directors

    JONATHAN GILBERT Executive Chairman Independent Director 1 trey Theson lose Red Ct Propaare ne prover ot Sous based Sd santoes obra shh BOARD OF DIRECTORS KEVIN J, ESVAL KENNETH E, PUZDER Director Keon €, Puree serves a Ciel Financ Ott ol Canes. a ‘sen tom Decomber f 2014 te present he hak sve a8 c=

  16. Slide 16: 2019 Milestones

    2019 MILESTONES sn FOR Tene rapt ant oe Q1, 2019 aan” Q3, 2019 IC ~ ~ ceed ar Q2, 2019 rainanenr 4, 2019 Srey a oe geet Seotngons eae “eo “oor ‘cma seporoets i EXACEUS

  17. Slide 17: Summary

    SUMMARY Majoty ownership in Exactus One Wora's two 100 acre indstral pomp farms Thi party valuation of Exactus One Wore’: )|_ estimated enterprise valve of $31,050,000, 4“ urchase order fr inventor [i stemoo0n a Y (5) Clan balance sheet and cap tte ‘Successfully raised over $4,000,000 through family

  18. Slide 18: Exactus: From the Seed to the Final Product

    EXAC#-US Fram The Seed To The Final Product, ly The Highest Standards. Leading The Way. Raising The Bar. Fee tutor information contact: Philip Young, Chief Executive Off Emel pyouna@exactusin. com ‘Andrew Johnson, Chief Strategy Officer mal aohnsont@exacusinc.com

Exactus — Investor Presentation (June 2019) on 6ix